tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OPTN Stock Latest News

Optinose announces peer-review publication on EDS-FLU efficacy
The FlyOptinose announces peer-review publication on EDS-FLU efficacy
15d ago
OPTN
New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery
PremiumPress Releases
New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery
15d ago
OPTN
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PremiumPress Releases
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
25d ago
OPTN
Optinose sees FY24 XHANCE net revenue $85M-$90M
PremiumThe Fly
Optinose sees FY24 XHANCE net revenue $85M-$90M
1M ago
OPTN
Optinose reports Q2 EPS (7c), consensus (8c)
PremiumThe Fly
Optinose reports Q2 EPS (7c), consensus (8c)
1M ago
OPTN
Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
PremiumPress ReleasesOptinose Announces Reporting Date for Second Quarter 2024 Financial Results
2M ago
OPTN
Expanded Access to XHANCE with Addition to National Commercial Formularies
Premium
Press Releases
Expanded Access to XHANCE with Addition to National Commercial Formularies
3M ago
OPTN
Optinose announces XHANCE added to Express Scripts’ national formularies
Premium
The Fly
Optinose announces XHANCE added to Express Scripts’ national formularies
3M ago
OPTN
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
PremiumPress Releases
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
4M ago
OPTN
Optinose price target lowered to $3 from $4 at Lake Street
PremiumThe Fly
Optinose price target lowered to $3 from $4 at Lake Street
4M ago
OPTN
Optinose sees 2024 XHANCE net revenue $85M-$95M
PremiumThe Fly
Optinose sees 2024 XHANCE net revenue $85M-$95M
4M ago
OPTN
Optinose reports Q1 EPS (12c), consensus (11c)
PremiumThe Fly
Optinose reports Q1 EPS (12c), consensus (11c)
4M ago
OPTN
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
PremiumPress ReleasesOptinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
4M ago
OPTN
OPTN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
OPTN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
OPTN
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
Premium
Press Releases
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
4M ago
OPTN
Optinose sees FY24 XHANCE net revenue at $85M-$95M
PremiumThe Fly
Optinose sees FY24 XHANCE net revenue at $85M-$95M
4M ago
OPTN
Optinose announces $55M registered direct offering at $1.00 per share
PremiumThe Fly
Optinose announces $55M registered direct offering at $1.00 per share
4M ago
OPTN
OptiNose Inc Raises $55 Million to Boost XHANCE Commercialization
PremiumCompany Announcements
OptiNose Inc Raises $55 Million to Boost XHANCE Commercialization
4M ago
8K
OPTN
Optinose provides corporate update on XHANCE launch
PremiumThe Fly
Optinose provides corporate update on XHANCE launch
5M ago
OPTN
Optinose reports preliminary Q1 XHANCE net revenue of $14.9M
PremiumThe FlyOptinose reports preliminary Q1 XHANCE net revenue of $14.9M
5M ago
OPTN
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
Premium
Press Releases
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
5M ago
OPTN
Optinose to Present at the Needham Virtual Healthcare Conference
Premium
Press Releases
Optinose to Present at the Needham Virtual Healthcare Conference
6M ago
OPTN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >